Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F P Castronovo

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Nuclear Medicine Communications|January 1, 1996
A software application to estimate exposure around 131I cancer and hyperthyroid patientsP J Weber, F P Castronovo
Health Physics|October 11, 1991
A local area network for controlling the ordering and purchasing of radioactive materialP J Weber, F P Castronovo
Radiology|December 1, 1981
Central venous pressure line localization with a cobalt-57 marker systemS A DeLuca, F P Castronovo
The New England Journal of Medicine|April 1, 1971
Tagged fibrinogen and hepatitisH P Pendergrass, F P Castronovo
The American Journal of Cardiology|January 1, 1985
Radiation exposure and protection in cardiac catheterization laboratoriesS W Miller, F P Castronovo
American Journal of Hospital Pharmacy|July 1, 1973
Development of technetium-99m labeled 1-hydroxy-ethylidene-1,1-disodium phosphonate for skeletal imagingR J Callahan, F P Castronovo
Nuclear Medicine Communications|September 20, 2000
Radioactivity in breast milk following 111In-octreotideF P Castronovo, H Stone, J Ulanski
Nuclear Medicine Communications|October 1, 1996
2-aminoethylphosphonic acid: biodistribution of a naturally occurring phosphonate after labelling with technetium-99mF P Castronovo, S Kopiwoda, M Peterson
International Journal of Nuclear Medicine and Biology|January 1, 1984
[99mTc]pyrophosphate and [125I]phenylphosphonate behavior in the infarcted rat myocardiumF P Castronovo, T Yasuda, H W Strauss
Nuclear Medicine Communications|October 1, 1984
Acute uptake and chronic retention of infarct avid myocardial-seeking agents: 99Tcm-pyrophosphate and 125I-phenylphosphateF P Castronovo, T Yasuda, H W Strauss
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Nuclear Medicine Communications|January 1, 1996
A software application to estimate exposure around 131I cancer and hyperthyroid patientsP J Weber, F P Castronovo
Health Physics|October 11, 1991
A local area network for controlling the ordering and purchasing of radioactive materialP J Weber, F P Castronovo
Radiology|December 1, 1981
Central venous pressure line localization with a cobalt-57 marker systemS A DeLuca, F P Castronovo
The New England Journal of Medicine|April 1, 1971
Tagged fibrinogen and hepatitisH P Pendergrass, F P Castronovo
The American Journal of Cardiology|January 1, 1985
Radiation exposure and protection in cardiac catheterization laboratoriesS W Miller, F P Castronovo
American Journal of Hospital Pharmacy|July 1, 1973
Development of technetium-99m labeled 1-hydroxy-ethylidene-1,1-disodium phosphonate for skeletal imagingR J Callahan, F P Castronovo
Nuclear Medicine Communications|September 20, 2000
Radioactivity in breast milk following 111In-octreotideF P Castronovo, H Stone, J Ulanski
Nuclear Medicine Communications|October 1, 1996
2-aminoethylphosphonic acid: biodistribution of a naturally occurring phosphonate after labelling with technetium-99mF P Castronovo, S Kopiwoda, M Peterson
International Journal of Nuclear Medicine and Biology|January 1, 1984
[99mTc]pyrophosphate and [125I]phenylphosphonate behavior in the infarcted rat myocardiumF P Castronovo, T Yasuda, H W Strauss
Nuclear Medicine Communications|October 1, 1984
Acute uptake and chronic retention of infarct avid myocardial-seeking agents: 99Tcm-pyrophosphate and 125I-phenylphosphateF P Castronovo, T Yasuda, H W Strauss
Pageof 8